Two In Vitro Studies on Eravacycline (XERAVA®) Presented at IDWeek, Demonstrating Its Sustained and Robust Antimicrobial Activity SHANGHAI, Nov. 22, 2024 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, "Everest", or… CISION PRNewswireNovember 22, 2024
Turfan Leads the Way: Electricity Drives Development of Smart Irrigation Demonstration Zone TURFAN, China, Nov. 22, 2024 /PRNewswire/ — On November 19, State Grid… CISION PRNewswireNovember 22, 2024
Press ReleaseSungrow Strengthens Australian Market Presence with 1.7GWh of C&I Energy Storage Partnerships with Raystech and Solar Juice SYDNEY, Nov. 22, 2024 /PRNewswire/ — Sungrow, the global leading PV inverter… CISION PRNewswireNovember 22, 2024
Global Times: Neo-Chinese cuisine: How China is reimagining its food heritage BEIJING, Nov. 22, 2024 /PRNewswire/ — The concept of beauty has intrigued… CISION PRNewswireNovember 22, 2024
Turfan's Real-Time Power Response System Boosts Regional Tourism TURFAN, China, Nov. 22, 2024 /PRNewswire/ — On November 19, State Grid… CISION PRNewswireNovember 22, 2024
Olverembatinib Surmounts Ponatinib and Asciminib Resistance and Is Well Tolerated in Patients With CML and Ph+ ALL: New Report in JAMA Oncology ROCKVILLE, Md. and SUZHOU, China, Nov. 22, 2024 /PRNewswire/ — Ascentage Pharma… CISION PRNewswireNovember 22, 2024
Olverembatinib Surmounts Ponatinib and Asciminib Resistance and Is Well Tolerated in Patients With CML and Ph+ ALL: New Report in JAMA Oncology ROCKVILLE, Md. and SUZHOU, China, Nov. 22, 2024 /PRNewswire/ — Ascentage Pharma… CISION PRNewswireNovember 22, 2024
Press ReleaseThe Global AI Defense Challenge 2024 Announces Winners Across Two Competition Tracks HANGZHOU, China, Nov. 22, 2024 /PRNewswire/ — The Global AI Defense Challenge… CISION PRNewswireNovember 22, 2024
